Indirect comparison between immunotherapy alone and immunotherapy plus chemotherapy as first-line treatment for advanced non-small cell lung cancer: a systematic review

Indirect comparison between immunotherapy alone and immunotherapy plus chemotherapy as first-line treatment for advanced non-small cell lung cancer: a systematic review

Bibliographic Details
Main Authors:	Fei Xu, Yuan Chen, Xiaoli Ren, Shu Xia
Format:	Article
Language:	English
Published:	BMJ Publishing Group 2020-11-01
Series:	BMJ Open
Online Access:	https://bmjopen.bmj.com/content/10/11/e034010.full

Similar Items

Comparative Efficacy and Safety of Immunotherapy Alone and in Combination With Chemotherapy for Advanced Non-small Cell Lung Cancer
by: Xue Wang, et al.
Published: (2021-03-01)

First-line Combination Immunotherapy in Advanced Non-small Cell Lung Cancer
by: Xiaoxiao PENG, et al.
Published: (2018-12-01)

Comparison of bevacizumab plus chemotherapy with chemotherapy alone in advanced non-small-lung cancer patients
by: Tang N, et al.
Published: (2016-07-01)

Advances in Lung Cancer Immunotherapy
by: Jing ZHAO, et al.
Published: (2009-05-01)

The between Now and Then of Lung Cancer Chemotherapy and Immunotherapy
by: Roberta Visconti, et al.
Published: (2017-06-01)

First Line Immunotherapy for Non-Small Cell Lung Cancer
by: Nicola J. Nasser, et al.
Published: (2020-11-01)

Comparison of the outcome between immunotherapy alone or in combination with chemotherapy in EGFR-mutant non-small cell lung cancer
by: Chia-I Shen, et al.
Published: (2021-08-01)

Advances in immunotherapy for treatment of lung cancer
by: Jean G. Bustamante Alvarez, et al.
Published: (2015-09-01)

An exceptional response to immunotherapy with chemotherapy in metastatic lung cancer
by: Xenia Elena BACINSCHI, et al.
Published: (2020-06-01)

First-line immune-checkpoint inhibitor plus chemotherapy chemotherapy alone for extensive-stage small-cell lung cancer: a meta-analysis
by: Thierry Landre, et al.
Published: (2020-12-01)

Chemo-immunotherapy as first-line treatment for small-cell lung cancer
by: Saira Farid, et al.
Published: (2020-12-01)

Chemotherapy plus Erlotinib versus Chemotherapy Alone for Treating Advanced Non-Small Cell Lung Cancer: A Meta-Analysis.
by: J L Xu, et al.
Published: (2015-01-01)

Immunotherapy Advances in Small Cell Lung Cancer
by: Yangyang XU, et al.
Published: (2020-11-01)

Advances of Immunotherapy in Small Cell Lung Cancer
by: Jingjing LIU, et al.
Published: (2014-06-01)

Immunotherapy Plus Cryotherapy: Potential Augmented Abscopal Effect for Advanced Cancers
by: Joe Abdo, et al.
Published: (2018-03-01)

Advance of Cellular Immunotherapy in Clinical and Translational Medicine of Lung Cancer
by: Fei YAN, et al.
Published: (2016-06-01)

Immunotherapy in non-small cell lung cancer: advancements and challenges
by: Fei Zhou, et al.
Published: (2021-05-01)

Immunotherapy in first-line treatment of recurrent non-small cell lung cancer
by: E. O. Rodionov, et al.
Published: (2019-12-01)

Weekly chemotherapy as first line treatment in frail head and neck cancer patients in the immunotherapy era
by: Andrea Botticelli, et al.
Published: (2021-07-01)

Efficacy and Safety of First-Line Immunotherapy in Combination with Chemotherapy for Patients with Extensive-Stage Small Cell Lung Cancer: A Systematic Review and Network Meta-Analysis
by: Bi-Cheng Wang, et al.
Published: (2020-01-01)

Hepatoid Adenocarcinoma of the Lung Responsive to Frontline Combination Chemotherapy With Immunotherapy: Case Report
by: Galina G. Lagos, MD, et al.
Published: (2021-02-01)

Cost-effectiveness of Immunotherapy for Locally Advanced or Metastatic Non-small Cell Lung Cancer after Chemotherapy
by: Chih-Wen Chang, et al.
Published: (2019)

A Trial of the Safety and Efficacy of Chemotherapy Plus Anlotinib vs Chemotherapy Alone as Second- or Third-Line Salvage Treatment for Advanced Non-Small Cell Lung Cancer
by: Wang H, et al.
Published: (2020-05-01)

Meta-analysis and indirect treatment comparison of modified FOLFIRINOX and gemcitabine plus nab-paclitaxel as first-line chemotherapy in advanced pancreatic cancer
by: Jiayuan Chen, et al.
Published: (2021-07-01)

Immune-checkpoint inhibitors plus chemotherapy versus chemotherapy as first-line treatment for patients with extensive-stage small cell lung cancer
by: Fei Zhou, et al.
Published: (2020-07-01)

Corrigendum to “Efficacy and Safety of First-Line Immunotherapy in Combination with Chemotherapy for Patients with Extensive-Stage Small Cell Lung Cancer: A Systematic Review and Network Meta-Analysis”
by: Bi-Cheng Wang, et al.
Published: (2021-01-01)

Combination of immunotherapy with chemotherapy and radiotherapy in lung cancer: is this the beginning of the end for cancer?
by: Chiara Lazzari, et al.
Published: (2018-04-01)

Cancer immunotherapy via combining oncolytic virotherapy with chemotherapy: recent advances
by: Simpson GR, et al.
Published: (2016-01-01)

Advances in Immunotherapies for Non-small Cell Lung Cancer
by: Yuan HE, et al.
Published: (2014-03-01)

Induction chemotherapy combined with immunotherapy in locally advanced head and neck squamous cell carcinoma
by: Xia Li, et al.
Published: (2021-05-01)

Immunotherapy for Lung Cancers
by: Ming-Yi Ho, et al.
Published: (2011-01-01)

Cellular Immunotherapy and the Lung
by: Sorcha Daly, et al.
Published: (2021-09-01)

Immune-checkpoint inhibitor plus chemotherapy versus conventional chemotherapy for first-line treatment in advanced non-small cell lung carcinoma: a systematic review and meta-analysis
by: Yixin Zhou, et al.
Published: (2018-12-01)

Intercalating and maintenance gefitinib plus chemotherapy versus chemotherapy alone in selected advanced non-small cell lung cancer with unknown EGFR status
by: Hong Jian, et al.
Published: (2017-08-01)

Blood microbiota diversity determines response of advanced colorectal cancer to chemotherapy combined with adoptive T cell immunotherapy
by: Duo Yang, et al.
Published: (2021-01-01)

Developments in Immunotherapy for Advanced Non-small Cell Lung Cancer
by: Haoyang LI, et al.
Published: (2021-02-01)

First-Generation EGFR-TKI Plus Chemotherapy Versus EGFR-TKI Alone as First-Line Treatment in Advanced NSCLC With EGFR Activating Mutation: A Systematic Review and Meta-Analysis of Randomized Controlled Trials
by: Qiang Wu, et al.
Published: (2021-04-01)

Failure of Immunotherapy—The Molecular and Immunological Origin of Immunotherapy Resistance in Lung Cancer
by: Justyna Błach, et al.
Published: (2021-08-01)

Neoadjuvant immunotherapy combined with chemotherapy for locally advanced squamous cell lung carcinoma: A case report and literature review
by: Zheng Yuan, et al.
Published: (2021-08-01)

Immunotherapy for Head and Neck Cancer: A Paradigm Shift From Induction Chemotherapy to Neoadjuvant Immunotherapy
by: Hirofumi Shibata, et al.
Published: (2021-09-01)